{"result":[{"lastName":"Gonzalgo","clinicalFocus":[{"focus":"Prostate Cancer - Robotic Prostatectomy"},{"focus":"Bladder Cancer - Robotic Cystectomy"},{"focus":"Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Urology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=13213&type=small&showNoImage","displayName":"Mark L. Gonzalgo, M.D., Ph.D.","firstName":"Mark","href":"http://med.stanford.edu/profiles/Mark_Gonzalgo","researchInterest":"My laboratory is focused on studying the role of DNA methylation in prostate and bladder cancer.  Certain genes and their downstream targets may be useful molecular markers for disease detection and prognostication. We are interested in utilizing methylation markers to detect abnormal changes in serum and urine.  Clinical Focus: Prostate Cancer - Robotic Prostatectomy; Bladder Cancer - Robotic Cystectomy; Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer."},{"lastName":"Srinivas","clinicalFocus":[{"focus":"Bladder Cancer"},{"focus":"Bladder Cancer - Medical Oncology"},{"focus":"Germ Cell Tumors"},{"focus":"Germ Cell Tumors - Medical Oncology"},{"focus":"Germ Cell Tumors - Urologic Oncology"},{"focus":"Kidney Cancer"},{"focus":"Kidney Cancer - Medical Oncology"},{"focus":"Male Cancers - Penile"},{"focus":"Male Cancers - Prostate "},{"focus":"Male Cancers - Testicular "},{"focus":"Oncology (Cancer)"},{"focus":"Penile Cancer"},{"focus":"Prostate Cancer"},{"focus":"Prostate Cancer - Medical Oncology"},{"focus":"Testicular Tumors"},{"focus":"Testicular Tumors - Medical Oncology"},{"focus":"Ureteral Cancer"},{"focus":"Ureteral Cancer - Medical Oncology"},{"focus":"Urethral Cancer"},{"focus":"Urethral Cancer - Medical Oncology"},{"focus":"Urologic Cancers"},{"focus":"Urologic Cancers - Medical Oncology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4350&type=small&showNoImage","displayName":"Sandy Srinivas","firstName":"Sandhya","href":"http://med.stanford.edu/profiles/Sandhya_Srinivas","researchInterest":"Clinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma"},{"lastName":"Brooks","clinicalFocus":[{"focus":"Male Cancers - Prostate "},{"focus":"Prostate Cancer"},{"focus":"Nerve-sparing radical prostatectomy"},{"focus":"Prostate Cancer - Urologic Oncology"},{"focus":"Urologic Cancers"},{"focus":"Urologic Cancers - Urologic Oncology"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor,Urology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6178&type=small&showNoImage","displayName":"James D. Brooks","firstName":"James","href":"http://med.stanford.edu/profiles/James_Brooks","researchInterest":"We use genomic approaches to identify disease biomarkers.  We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer."},{"lastName":"Yemoto","clinicalFocus":[],"appointments":[{"appointment":"Biosafety, Web & Compliance Specialist,Dean's Office - Finance & Administration, Health & Safety"},{"appointment":"Health & Safety Specialist,Dean's Office - Finance & Administration, Health & Safety"}],"primaryAppointment":"Biosafety, Web & Compliance Specialist,Dean's Office - Finance & Administration, Health & Safety","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=26030&type=small&showNoImage","displayName":"Cheryl Yemoto","firstName":"Cheryl","href":"http://med.stanford.edu/profiles/Cheryl_Yemoto","researchInterest":""},{"lastName":"West","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6327&type=small&showNoImage","displayName":"Dee W. West","firstName":"Dee","href":"http://med.stanford.edu/profiles/Dee_West","researchInterest":"- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer\r\n- Cancer surveillance (Cancer registration, cancer patterns)\r\n- Cancer outcomes (Survival, quality of life, quality of care)"},{"lastName":"John","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7425&type=small&showNoImage","displayName":"Esther M. John","firstName":"Esther","href":"http://med.stanford.edu/profiles/Esther_John","researchInterest":"Etiology of breast, prostate and ovarian cancer; cancer in Hispanics and African-Americans; migration and acculturation in Hispanics; modifiable lifestyle factors (vitamin D, physical activity, body size, heterocyclic amines, occupational exposures); genetic susceptibility; gene-environment interactions"},{"lastName":"Balise","clinicalFocus":[],"appointments":[{"appointment":"Sr Research Engineer,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Sr Research Engineer,Health Research & Policy - Epidemiology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=25948&type=small&showNoImage","displayName":"Raymond Balise","firstName":"Raymond","href":"http://med.stanford.edu/profiles/Raymond_Balise","researchInterest":""},{"lastName":"Tibshirani","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Natural Sciences Cluster - Statistics"}],"primaryAppointment":"Professor,Health Research & Policy - Biostatistics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4688&type=small&showNoImage","displayName":"Robert Tibshirani","firstName":"Robert","href":"http://med.stanford.edu/profiles/Robert_Tibshirani","researchInterest":"My research is in applied statistics and biostatistics. I specialize in \u000bcomputer-intensive methods for regression and classification, bootstrap, cross-validation\u000band statistical inference, and signal and image analysis for medical diagnosis."},{"lastName":"Whittemore","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Epidemiology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Health Research & Policy - Epidemiology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4482&type=small&showNoImage","displayName":"Alice S Whittemore","firstName":"Alice","href":"http://med.stanford.edu/profiles/Alice_Whittemore","researchInterest":"Cancers of the prostate, breast and ovary account for a major proportion of new cancer cases and cancer deaths in the U.S. each year. Our recent research focus has been on developing improved statistical methods for the design and conduct of studies involving hereditary predisposition and modifiable lifestyle characteristics in the etiologies of site-specific cancers."},{"lastName":"Horn-Ross","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7424&type=small&showNoImage","displayName":"Pamela Horn-Ross","firstName":"Pamela","href":"http://med.stanford.edu/profiles/Pamela_Horn-Ross","researchInterest":"My research interests focus on nutrition and the etiology of hormonally-dependent cancers in women (most particularly breast, endometrial, and thyroid cancers).  Of particular interest are the effects of phytochemicals that may reduce cancer risk, such as the isoflavones in soy foods, the lignans in whole grains, the isothiocyanates in broccoli and other cruciferous vegetables, and resveratrol in red wine and peanuts. Nutrient-gene interactions are also of interest."},{"lastName":"Peehl","clinicalFocus":[],"appointments":[{"appointment":"Professor (Research),Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor (Research),Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4633&type=small&showNoImage","displayName":"Donna Peehl, PhD","firstName":"Donna","href":"http://med.stanford.edu/profiles/Donna_Peehl","researchInterest":"My research focuses on the molecular and cellular biology of the human prostate. Developing realistic experimental models is a major goal, and primary cultures of prostatic epithelial and stromal cells are my main model system. Our discoveries are relevant to prevention, detection, diagnosis and treatment of benign and malignant prostatic diseases."},{"lastName":"Goodman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - General Medical Disciplines"},{"appointment":"Professor,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Professor,Medicine - General Medical Disciplines","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=23410&type=small&showNoImage","displayName":"Steven Goodman","firstName":"Steven","href":"http://med.stanford.edu/profiles/Steven_Goodman","researchInterest":"I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research. Finally, I have an ongoing project related to landmark clinical trials that have had great impact."},{"lastName":"Olshen","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor (By courtesy),Natural Sciences Cluster - Statistics"},{"appointment":"Professor (By courtesy),Electrical Engineering"}],"primaryAppointment":"Professor,Health Research & Policy - Biostatistics","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4324&type=small&showNoImage","displayName":"Richard A. Olshen","firstName":"Richard","href":"http://med.stanford.edu/profiles/Richard_Olshen","researchInterest":"My research is in statistics and their applications to medicine and biology. Many efforts have concerned tree-structured algorithms for classification, regression, survival analysis, and clustering."},{"lastName":"Friedman","clinicalFocus":[],"appointments":[{"appointment":"Consulting Professor,Health Research & Policy - Epidemiology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Consulting Professor,Health Research & Policy - Epidemiology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=6143&type=small&showNoImage","displayName":"Gary Friedman","firstName":"Gary","href":"http://med.stanford.edu/profiles/Gary_Friedman","researchInterest":"Chronic disease epidemiology, particularly cancer, cardiovascular disease, adverse effects of smoking, alcohol and pharmaceuticals, evaluation of screening tests.\r\nMost of my career has been in the Kaiser Permanente Division of Research where I was Director for 7 years and am still active. I especially enjoy mentoring students and trainees at Stanford."},{"lastName":"Ford","clinicalFocus":[{"focus":"Cancer Genetics"},{"focus":"Gastrointestinal Cancers - Genetics"},{"focus":"Gastrointestinal Cancers - Medical Oncology"},{"focus":"Breast Cancer - Genetics"},{"focus":"Ovarian Cancer - Genetics"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Associate Professor,Genetics"},{"appointment":"Associate Professor (By courtesy),Pediatrics"}],"primaryAppointment":"Associate Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4066&type=small&showNoImage","displayName":"James Ford","firstName":"James","href":"http://med.stanford.edu/profiles/James_Ford","researchInterest":"Mammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA\u000bdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer."},{"lastName":"Higgins","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4038&type=small&showNoImage","displayName":"John Higgins","firstName":"John","href":"http://med.stanford.edu/profiles/John_Higgins","researchInterest":"I work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology."},{"lastName":"Leppert","clinicalFocus":[],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=10322&type=small&showNoImage","displayName":"John Leppert","firstName":"John","href":"http://med.stanford.edu/profiles/John_Leppert","researchInterest":"Our research aims to improve the global quality of care for patients with Urologic cancer with a particular focus on kidney cancer. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are investigating nanofluidic proteomic assays to diagnose kidney cancer and signatures of response to therapy. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions."},{"lastName":"Cho-Phan","clinicalFocus":[{"focus":"Gastrointestinal Cancers"},{"focus":"Medical Oncology"},{"focus":"Oncology (Cancer)"}],"appointments":[{"appointment":"Clinical Assistant Professor,Medicine - Oncology"}],"primaryAppointment":"Clinical Assistant Professor,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=3864&type=small&showNoImage","displayName":"Cheryl Cho-Phan","firstName":"Cheryl","href":"http://med.stanford.edu/profiles/Cheryl_Cho-Phan","researchInterest":""},{"lastName":"Gomez","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7427&type=small&showNoImage","displayName":"Scarlett Lin Gomez","firstName":"Scarlett","href":"http://med.stanford.edu/profiles/Scarlett_Gomez","researchInterest":"As a cancer epidemiologist with a focus on surveillance research and social epidemiology, Dr. Gomez conducts research in two broad areas:  1) methodologic studies aimed at enhancing cancer registry data for studies of race/ethnicity and social determinants in cancer incidence and outcomes; and 2) studies to elucidate the underlying social factors responsible for racial/ethnic and socioeconomic health disparities, particularly those identified through surveillance data."},{"lastName":"Oakley-Girvan","clinicalFocus":[],"appointments":[{"appointment":"Consulting Assistant Professor,Health Research & Policy"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Consulting Assistant Professor,Health Research & Policy","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=7432&type=small&showNoImage","displayName":"Ingrid Oakley-Girvan","firstName":"Ingrid","href":"http://med.stanford.edu/profiles/Ingrid_Oakley-Girvan","researchInterest":"Evaluating factors associated with racial disparities in prostate and breast cancer diagnosis, progression and survival.\r\nEvaluating genetic factors and gene/environment interactions involved in prostate and breast cancer incidence, progression and survival.\r\nAssessing quality of life and survivorship issues two or more years after diagnosis.\r\nProviding information and community-based solutions to improve public health."},{"lastName":"van de Rijn","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Sarcoma"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","displayName":"Matt van de Rijn","firstName":"Matt","href":"http://med.stanford.edu/profiles/Matt_van de Rijn","researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis."},{"lastName":"Skinner","clinicalFocus":[{"focus":"Cancer > urologic oncology"},{"focus":"Bladder Cancer"},{"focus":"Continent urinary reservoir"},{"focus":"urinary tract reconstruction"},{"focus":"testis cancer"},{"focus":"Kidney Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor - Med Center Line,Urology"}],"primaryAppointment":"Professor - Med Center Line,Urology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=32891&type=small&showNoImage","displayName":"Eila C. Skinner","firstName":"Eila","href":"http://med.stanford.edu/profiles/Eila_Skinner","researchInterest":"My research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer.  This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management.  I have also focused on optimizing the  use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life."},{"lastName":"Blayney","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"Cancer Survivorship"},{"focus":"Breast cancer"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://med.stanford.edu/profiles/viewImage?facultyId=18330&type=small&showNoImage","displayName":"Douglas W. Blayney","firstName":"Douglas","href":"http://med.stanford.edu/profiles/Douglas_Blayney","researchInterest":"Use of medical informatics to improve quality delivery in cancer care"}]}